Pentoxifylline in the Treatment of NEC in Premature Neonates
Status:
Unknown status
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Pentoxifylline improves microcirculation and decreases TNF alpha levels associated with
sepsis, rendering it of potential therapeutic value in necrotizing enterocolitis in premature
neonates.